首页> 美国卫生研究院文献>World Journal of Gastroenterology >Late SV40 factor: A key mediator of Notch signaling in human hepatocarcinogenesis
【2h】

Late SV40 factor: A key mediator of Notch signaling in human hepatocarcinogenesis

机译:晚期SV40因子:人肝癌发生过程中Notch信号的关键介体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the relationship between late SV40 factor (LSF) and Notch signaling in the development and progress of hepatocellular carcinoma (HCC).METHODS: Liver cancer tissue specimens from 25 patients were analyzed for Notch-1 and LSF expression by immunohistochemistry. The correlation between expression and the biological effects of Notch-1 and LSF were analyzed using genetic and pharmacological strategies in HCC cell lines and human normal cell lines, including hepatic stellate cells (HSC) and human embryonic kidney epithelial cells (HEK).RESULTS: Immunohistochemistry showed that both Notch-1 and LSF were significantly upregulated in HCC samples (76%, 19/25, P < 0.0001 and 84%, 21/25, P < 0.0001, respectively) compared with non-cancer samples. Activation of Notch-1 by exogenous transfection of Notch1 intracellular domain increased LSF expression in HSC and HEK cells to levels similar to those seen in HepG2 cells. Furthermore, blocking Notch-1 activation with a γ-secretase inhibitor, DAPT, downregulated LSF expression in HepG2 cells. Additionally, a biological behavior assay showed that forced overexpression of LSF promoted HepG2 cell proliferation and invasion.CONCLUSION: LSF is a key mediator of the Notch signaling pathway, suggesting that it might be a novel therapeutic target for the treatment of HCC.
机译:目的:探讨晚期SV40因子(LSF)与Notch信号在肝细胞癌(HCC)发生发展中的关系。方法:采用免疫组织化学方法分析25例肝癌组织中Notch-1和LSF的表达。使用遗传和药理学策略分析了HCC细胞系和人类正常细胞系(包括肝星状细胞(HSC)和人类胚胎肾上皮细胞(HEK))中Notch-1和LSF的表达与生物学效应之间的相关性。结果:免疫组织化学显示,与非癌样品相比,HCC样品中的Notch-1和LSF均显着上调(分别为76%,19/25,P <0.0001和84%,21/25,P <0.0001)。 Notch1胞内域的外源转染激活Notch-1可使HSC和HEK细胞中LSF的表达增加到类似于HepG2细胞中看到的水平。此外,用γ-分泌酶抑制剂DAPT阻断Notch-1激活可下调HepG2细胞中LSF的表达。此外,生物学行为分析表明,强迫性LSF的过量表达促进了HepG2细胞的增殖和侵袭。结论:LSF是Notch信号通路的关键介质,提示它可能是治疗HCC的新靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号